Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELX-02 in Nephropathic Cystinosis
NCT04069260Phase 2Terminated
- Start
- Aug 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exaluren in nephropathic cystinosis. Started Aug 2019; status: terminated.
02
Drugs
exaluren
03
Conditions
nephropathic cystinosis
Beyond the preview
Go deeper on NCT04069260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069260.